Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

NCT00410592 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Esomeprazole 40mg
DRUG: Pantoprazole 40mg
DRUG: Lansoprazole 30mg

Sponsor

AstraZeneca